Dr. Robert L. Villalobos Jr., MD

Dr. Villalobos practices at Southwestern Eye Center in Las Cruces, New Mexico.

Dr. Villalobos' NPI, 1285682674, was assigned on May 5, 2006. Dr. Villalobos holds New Mexico license NM83137.

Dr. Villalobos' primary practice is Southwestern Eye Center, at 2030 S Solano Dr, Las Cruces, NM 88001 in Dona Ana County. The practice phone is (480) 892-8400.

Dr. Villalobos' primary practice is Southwestern Eye Center in Las Cruces, New Mexico. Dmand AI also links Dr. Villalobos to 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Villalobos practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Villalobos' primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Villalobos is licensed in New Mexico.

Dmand AI lists age-related macular degeneration, cataract, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Villalobos treats.

CMS data shows 1,801 Medicare services from Dr. Villalobos across 13 procedure codes in 2024, for 740 Medicare patients. Medicare paid $172,561 for them. Every service was in an office.

CMS counts 740 Medicare patients who saw Dr. Villalobos in 2024. The largest group is 75 to 84, with 286 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.13, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Villalobos' median patient age at 71, with 56% women.

In 2024, Dr. Villalobos wrote 1,751 Medicare Part D claims for 355 patients. 65% of them were for generic drugs. CMS names the drug for 1,593 of them, across 18 drugs with 11 or more claims each, at $162,902 in total drug cost. In 2023, CMS named 1,629 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Villalobos for performance year 2024, reported as part of a group. Dr. Villalobos accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 65 general payments to Dr. Villalobos from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Alimera Sciences, Inc. paid the most, $624.

Dmand AI lists 3 awards for Dr. Villalobos, most recently ACS Fellow in 2013.

Dr. Villalobos is in network with 15 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.